The Next Frontier of Drug Pricing Reform
Wednesday, June 21, at 1:00 p.m. ET / 10:00 a.m. PT
Pharmacy benefit managers are intermediaries that are supposed to negotiate lower drug costs. But does the system work for patients? And how can we fix it when it doesn’t?
- U.S. Sen. Chuck Grassley, (R-IA), Ranking Member of the Senate Budget Committee, Former Chairman of the Senate Finance and Judiciary Committees; President Pro Tempore Emeritus
- Rachel Cohrs, Washington Correspondent, STAT (moderator)
- Alex Oshmyansky, MD, Ph.D., CEO and Founder, Mark Cuban Cost Plus Drug Company
- Ed Silverman, Pharmalot Columnist, Senior Writer, STAT (moderator)